leisure time -WSS

leisure time

author：comprehensive 2025-10-01 02:44:28 - browse：58216

Kuldeep Singh Rajput -- health tech coverage from STAT — Kuldeep Singh Rajput has left his role as CEO of Biofourmis. World Economic Forum

A month after conducting significant layoffs, Biofourmis is out a CEO: Kuldeep Singh Rajput, one of the company’s founders, has quietly stepped down from his role.

A Biofourmis spokesperson confirmed Rajput’s departure to STAT on Wednesday, and said that while the company hunts for a new CEO it will be helmed by a committee of executives overseen by new board member Ben Wanamaker, a partner at Biofourmis investor General Atlantic. The Boston-based company was valued at $1.3 billion following a $320 million Series D financing round which closed last summer and brought big names to Biofourmis: CVS Health was an investor, and Omar Ishrak, former CEO of Medtronic, and Sachin Jain, CEO of the SCAN Health Plan joined the board.

Founded in 2015, Biofourmis has been developing a dizzying array of tech-enabled care offerings, including home-based care services for hospitals, clinical trials support for biopharma companies, and a pipeline of software-based interventions for heart failure and other conditions.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Think you might have Covid

WSS

Medicare Advantage insurers pressure Biden for bigger payments

Readout LOUD podcast, live from the STAT Breakthrough Summit East

AI generated plenty of interest at JPM but not a lot of trust

Steward Health Care expansion into Malta flopped

Pregnancy ages women, but effects reverse after delivery

Diabetes management: Digital health tools fall short, study says

explore

leisure time

explore

Medicare proposal to cover medical devices draws a mixed reaction

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

CRISPR technology availability, affordability needs to be expanded

Activists slam private health insurers over coverage restrictions

6 surprising facts about sugar

Trump demands the U.S. pay no more for drugs than other countries … again

Biotech investment managers search for lucrative opportunities

hotspot

Readout LOUD podcast, live from the STAT Breakthrough Summit East

Biotech investment managers search for lucrative opportunities

Diabetes management: Digital health tools fall short, study says

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

Medical devices makers are asking for forgiveness, not permission

Erich Jarvis studies song birds to learn about human stuttering

focus

focus

Wikipedia

Wikipedia